Ulf Ljungberg
Algemeen Directeur bij AnaMar AB
Oorsprong van het eerstegraads netwerk van Ulf Ljungberg
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.
15
| Subsidiary | Miscellaneous Commercial Services | 15 |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden.
3
| Extinct | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ulf Ljungberg via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| PPG INDUSTRIES, INC. | Industrial Specialties | Director/Board Member | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| RECIPHARM AB (PUBL) | Biotechnology | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
Gastrointestinal Associates PC
 Gastrointestinal Associates PC Medical/Nursing ServicesHealth Services Gastrointestinal Associates PC provides treatment for gastrointestinal problems. The private company is based in Knoxville, TN. | Medical/Nursing Services | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Leeds | College/University | Graduate Degree | |
Zeneca Garden Care
 Zeneca Garden Care Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| OREXO AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of Reading | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
| University of Uppsala | College/University | Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal | |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Umea Universitet | College/University | Corporate Officer/Principal Graduate Degree | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| King's College London | College/University | Doctorate Degree Corporate Officer/Principal | |
| Molecular Biology Consultants | Director/Board Member | ||
| University of Gothenburg | College/University | Doctorate Degree Corporate Officer/Principal | |
Koncentra Holding AB
 Koncentra Holding AB Investment ManagersFinance Koncentra Holding AB operates as an investment holding company. It is a privately held investment company with a focus on long-term investments within a range of different industries. The company was founded in 1999 and is headquartered in Stockholm, Sweden. | Investment Managers | Chairman Comptroller/Controller/Auditor | |
| BONESUPPORT HOLDING AB | Medical Specialties | Director of Finance/CFO Director/Board Member | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Pharmacia Ophthalmics AB | Corporate Officer/Principal Corporate Officer/Principal | ||
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| BIOARCTIC AB | Pharmaceuticals: Major | Director/Board Member | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
UCB Pharma SA (Belgium)
 UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Astra Hässle AB | Director/Board Member | ||
| LIPIDOR AB | Miscellaneous Commercial Services | Director/Board Member | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Operating Officer | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
| Analgesia Partnership | Corporate Officer/Principal | ||
BONE SUPPORT AB
 BONE SUPPORT AB Medical SpecialtiesHealth Technology BONE SUPPORT AB manufactures orthopedic supplies and equipment. Its products include cerament bone void filler, cerament G with gentamicin, cerament V with vancomycin. The company was founded by Lars Ake Alvar Lidgren in 1999 and is headquartered in Lund, Sweden. | Medical Specialties | Director of Finance/CFO Director/Board Member | |
Disruptive Materials AB
 Disruptive Materials AB Chemicals: Major DiversifiedProcess Industries Disruptive Materials AB manufactures mesoporous magnesium carbonate. It focuses on commercializing the material Upsalite that can be used in applications such as desiccant for humidity control, pharmaceutics, adsorbent for waste handling, thermal and acoustic insulation, cosmetics, adsorbent in ink jet paper,and bio material applications. The company was founded by Johan A. V. Gómez de la Torre, Maria Strømme, Lars-Erik Mattias Karls, and Sara Kristina Frykstrand Ångström in December 2011 and is headquartered in Uppsala, Sweden. | Chemicals: Major Diversified | Director/Board Member | |
| GABATHER AB | Pharmaceuticals: Major | Director/Board Member | |
| CORLINE BIOMEDICAL AB | Medical Specialties | Director/Board Member | |
Immuneed AB
 Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Medical Specialties | Chief Executive Officer | |
| EMPLICURE AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
| SP Process Development AB | Director/Board Member | ||
| INITIATOR PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
Haracon AB
 Haracon AB Miscellaneous Commercial ServicesCommercial Services Haracon AB provides corporate consulting services. | Miscellaneous Commercial Services | Director/Board Member | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
The Association of Corporate Treasurers
 The Association of Corporate Treasurers Miscellaneous Commercial ServicesCommercial Services The Association of Corporate Treasurers operates as an international professional body that specializes in the profession of corporate treasury. The firm offers education, training and grow network. It guides, informs and supports through technical work, webinars and publications. The company was founded in 1979 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Disruptive Pharma AB
 Disruptive Pharma AB Pharmaceuticals: MajorHealth Technology Disruptive Pharma AB is a pharmaceutical company based in Uppsala, Sweden, with a passion for innovation in drug products. The Swedish company has perfected the groundbreaking mesoporous magnesium carbonate (mmc) drug delivery technology, which makes it easier to develop amorphous drug candidates. By combining the mmc formulation technology with drug compounds, they can enhance existing products or assist in formulating new therapies. Disruptive Pharma seeks commercial partnership or licensing to industry partners within the drug improvement business area. The company was founded in 2018 by Maria Strömme, and the CEO is Peter Åsberg. | Pharmaceuticals: Major | Director/Board Member | |
Strike Pharma AB
 Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
| Zweden | 35 |
| Verenigd Koninkrijk | 9 |
| Verenigde Staten | 5 |
| Noorwegen | 2 |
| België | 2 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Process Industries | 3 |
| Finance | 3 |
Operationeel
| Director/Board Member | 250 |
| Corporate Officer/Principal | 137 |
| Chairman | 69 |
| Independent Dir/Board Member | 54 |
| Chief Executive Officer | 39 |
Sterkste connecties
| Insiders | |
|---|---|
| Sven Håkan Björklund | 46 |
| Joseph Jimenez | 32 |
| Staffan Encrantz | 28 |
| Anders Olof Adolf Ekblom | 27 |
| Eva Ulrika Sjökvist Saers | 26 |
| Peter Kiener | 25 |
| Gunilla Anders Ekström | 22 |
| Michele Hooper | 21 |
| Björn Westberg | 21 |
| Jane Ellen Henney | 20 |
| Gavin Hill | 20 |
| Graham Dixon | 18 |
| Tim Watts | 17 |
| Kjell Göran Stenberg | 14 |
| Andrew Howden | 14 |
- Beurs
- Insiders
- Ulf Ljungberg
- Bedrijfsconnecties